Implementation of a North Dakota Opioid Misuse and Overdose Prevention Program in West Virginia.
Journal
Journal of the American Pharmacists Association : JAPhA
ISSN: 1544-3450
Titre abrégé: J Am Pharm Assoc (2003)
Pays: United States
ID NLM: 101176252
Informations de publication
Date de publication:
02 Jul 2024
02 Jul 2024
Historique:
received:
19
12
2023
revised:
28
05
2024
accepted:
25
06
2024
medline:
5
7
2024
pubmed:
5
7
2024
entrez:
4
7
2024
Statut:
aheadofprint
Résumé
Pharmacy has an important role in combating the opioid epidemic. However, there is a need for more consistency of programs and evidence-based practices across the country. To describe how an evidence-based opioid misuse and overdose prevention program that originated in North Dakota was implemented in West Virginia and to compare program results between the two states including pharmacist interventions and patient screening for opioid misuse and overdose. This advancement in practice took place in participating North Dakota and West Virginia community pharmacies. An evidence-based program that originated in North Dakota was implemented in West Virginia. The details of this collaboration are outlined in this manuscript. Program screening and pharmacist intervention data were collected using DocStation, an online pharmacy patient management platform. Thirty-four pharmacies in West Virginia implemented the program. Between April 2022 and September 2023, a total of 34 West Virginia pharmacies conducted 449 documented screenings compared to 12,105 screenings by 81 pharmacies in North Dakota over the same time. There were differences between the states with regard to the proportion of individuals screened as high-risk for OUD and individuals at risk of accidental opioid overdose likely attributable to different demographics. An opioid misuse and prevention program was successfully implemented in two states, which can serve as a model to implement similar programs in other pharmacies across the United States.
Sections du résumé
BACKGROUND
BACKGROUND
Pharmacy has an important role in combating the opioid epidemic. However, there is a need for more consistency of programs and evidence-based practices across the country.
OBJECTIVES
OBJECTIVE
To describe how an evidence-based opioid misuse and overdose prevention program that originated in North Dakota was implemented in West Virginia and to compare program results between the two states including pharmacist interventions and patient screening for opioid misuse and overdose.
PRACTICE DESCRIPTION
METHODS
This advancement in practice took place in participating North Dakota and West Virginia community pharmacies.
PRACTICE INNOVATION
METHODS
An evidence-based program that originated in North Dakota was implemented in West Virginia. The details of this collaboration are outlined in this manuscript.
EVALUATION METHODS
METHODS
Program screening and pharmacist intervention data were collected using DocStation, an online pharmacy patient management platform.
RESULTS
RESULTS
Thirty-four pharmacies in West Virginia implemented the program. Between April 2022 and September 2023, a total of 34 West Virginia pharmacies conducted 449 documented screenings compared to 12,105 screenings by 81 pharmacies in North Dakota over the same time. There were differences between the states with regard to the proportion of individuals screened as high-risk for OUD and individuals at risk of accidental opioid overdose likely attributable to different demographics.
CONCLUSION
CONCLUSIONS
An opioid misuse and prevention program was successfully implemented in two states, which can serve as a model to implement similar programs in other pharmacies across the United States.
Identifiants
pubmed: 38964591
pii: S1544-3191(24)00172-9
doi: 10.1016/j.japh.2024.102152
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
102152Informations de copyright
Copyright © 2024. Published by Elsevier Inc.